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NS4BThe transmembrane NS4B protein of dengue virus (DENV) is a validated antiviral target that plays important
roles in viral replication and invasion of innate immune response. The ﬁrst 125 amino acids of DENV NS4B are
sufﬁcient for inhibition of alpha/beta interferon signaling. Resistancemutations toNS4B inhibitors are allmapped
to the ﬁrst 125 amino acids. In this study, we expressed and puriﬁed a protein representing the ﬁrst 125 amino
acids of NS4B (NS4B1–125). This recombinant NS4B1–125 protein was reconstituted into detergent micelles. Solu-
tion NMR spectroscopy demonstrated that there are ﬁve helices (α1 toα5) present in NS4B1–125. Dynamic stud-
ies, together with a paramagnetic relaxation enhancement experiment demonstrated that four helices, α2, α3,
α4, and α5 are embedded in the detergent micelles. Comparison of wild type and V63I mutant (a mutation
that confers resistance to NS4B inhibitor) NS4B1–125 proteins demonstrated that V63Imutation did not cause sig-
niﬁcant conformational changes, however, V63 may have a molecular interaction with residues in the α5 trans-
membrane domain under certain conditions. The structural and dynamic information obtained in study is helpful
to understand the structure and function of NS4B.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Dengue virus (DENV) containing four serotypes (DENV 1–4) is a
mosquito-transmitted member of the Flavivirus genus [1]. DENV can
cause diseases in humans, including dengue fever, dengue hemorrhagic
fever, and dengue shock syndrome. Itwas estimated that DENV infected
50 to 100 million people in tropical and subtropical regions all over the
world [2]. There is no clinically approved vaccine and antiviral drug to
prevent or treat DENV infection [3]. Understanding the molecular
mechanism of DENV replicationwill be useful for drug development [4].
DENV contains a single-strand, positive-sense RNA genome that can
be translated to a viral polyprotein. This polyprotein is co- and post-
translationally processed into three structural (C, prM, and E) and
seven non-structural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A,
NS4B, and NS5) by host and viral proteases (NS3). Among the seven
NS proteins, NS3 and NS5 have been well studied for their structures
and functions. NS3 is a multi-function protein possessing protease,
RNA helicase, and RTPase/NTPase activities [5–7]. NS5 is also a multi-
function protein with an N-terminal methyltransferase domain#03-01, 138669, Singapore.
@etc.a-star.edu.sg (C. Kang).followed by a C-terminal RNA-dependent RNA polymerase domain [8,
9]. NS2A, NS2B, NS4A and NS4B are integral membrane proteins that
are localized on the endoplasmic reticulum (ER) membrane. Accumu-
lated studies have shown that these membrane proteins are important
for viral replication though protein–protein interactions [7,10]. For ex-
ample, NS2B is an essential cofactor for the protease activity of NS3
[11]. NS4B can form complexes with both NS3 and NS4A [12–14].
NS4B contains 248 amino acids and is the largest nonstructural
membrane protein in DENV [15]. DENV NS4B exhibits high sequence
homology with other virus such as West Nile virus (WNV). NS4B of
Hepatitis C virus (HCV) has low sequence homology with DENV NS4B
and was shown to have signal transduction activity and nucleotide-
binding activity [16,17]. DENV NS4B co-localizes with components of
viral replication complex such as NS3, NS5, and double-stranded RNA
[15]. NS4B from WNV has been demonstrated to accumulate in the
perinuclear region and to translocate into the nuclear region [18]. Muta-
genesis studies of NS4B suggested that this protein is essential for viral
replication and pathogenesis. Single amino acid mutation (P38G) in
WNVNS4Bwas shown to be associatedwith both temperature sensitive
and small-plaque phenotypes [19]. For DENV-4 NS4B, a single mutation
(P104L) can abolish its interaction with NS3 [10]. Due to its importance
in viral replication, NS4B is an antiviral target for DENV drug discovery
[20]. A high-throughput screening using a DENV replicon cell line
Fig. 1.Membrane topology of NS4B. A. Membrane topology of NS4B obtained from a pre-
vious study [15]. B. The amino acid sequence of NS4B1–125 used in this study. Three possi-
ble membrane-interacting regions based on HMMTOP server prediction are labeled with
boxes. Resides 126–129 are not included in the construct, as indicated by a strikeout. C.
TMHMM prediction of NS4B1–125. The probability (0–1) to be a transmembrane domain
is plotted against residue number.
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block viral RNA replication through targeting NS4B protein [21,22].
The ﬁrst class of inhibitors contains an aminothiazole core. Resis-
tance mutations of the aminothiazole compounds were mapped to
NS4B P104 and A119 residues [23]. The second class of inhibitors con-
tains a spiropyrazolopyridone core, and the resistance mutation was
consistently mapped to NS4B V63 residue. The spiropyrazolopyridone
compound was shown to bind directly to recombinant NS4B protein
in vitro [21,22].
Structural analysis to understand the membrane topology of NS4B
from Flavivirus has been conducted using different methods [15,24,
25]. For DENV NS4B, biochemical experiments suggest that there are
two hydrophobic segments at its N-terminus interacting with the ER
lumen side of the membrane; the C-terminal part of DENV NS4B
contains three transmembrane segments [15]. A recent study investi-
gated the membrane topology of DENV NS4B using a peptide library
encompassing the full-length NS4B [26]. By observing the effect of the
peptides from NS4B on the membrane integrity, two more transmem-
brane segments at the N-terminus of NS4B were identiﬁed [26]. A de-
tailed secondary structure and membrane topology for the N-terminal
region of dengueNS4B still remain to bedetermined. NMR spectroscopy
has been a useful tool to study protein andmembrane interactions such
as the N-terminal region of DENV NS4A and NS2B [27,28]. To under-
stand the structure of the N-terminal region of DENV NS4B, a construct
encompassing residues 1 to 125 of DENV-2NS4Bwas expressed and pu-
riﬁed into detergentmicelles. Our study has provided structural and dy-
namic analysis of this construct. Such information will be useful for
further structural and functional analysis of NS4B protein.
2. Materials and methods
2.1. Materials
The DNA polymerase and the restriction enzymes were purchased
fromNewEngland Biolabs (Beverly, USA). The pET-29b plasmid for pro-
tein expression was purchased from Merck (Germany). Escherichia coli
BL21 (DE3) was purchased from Stratagene (La Jolla, USA). Protein pu-
riﬁcation system and PD10 desalting column were purchased from GE
Healthcare (Uppsala, Sweden). The SDS-PAGE system, the NuPAGE®
gels, SDS-PAGE running buffer and the SDS-PAGE molecular weight
standard were obtained from Invitrogen (Carlsbad, USA). The Ni2+-
nitrilotriacetic acid (NTA) afﬁnity resin, the PCR puriﬁcation kit and
the plasmid extraction kit were purchased from Qiagen (Gmbh,
Germany). Isopropyl β-D-1-thiogalactopyranoside (IPTG), dithiothreitol
(DTT) and detergents such as dodecylphosphocholine (DPC) and lyso-
myristoyl phosphatidylglycerol (LMPG) were purchased from Anatrace
(Maumee, USA) or Avanti Polar Lipids (Birmingham, USA). The 15NH4Cl,
13C-glucose and D2O were obtained from Cambridge Isotope Laborato-
ries (Andover, USA). All other chemicals used in this study were pur-
chased from Sigma-Aldrich (St. Louis, USA).
2.2. Protein expression and puriﬁcation
The cDNA coding residues 1–125 NS4B of DENV-2 (NS4B1–125) were
synthesized by Genscript and cloned into the Nde I and Xho I sites of
pET-29b to generate a new plasmid-pET29-NS4B-1–125. There are
seven non-viral residues (EHHHHHH) at the C-terminus to aid in protein
puriﬁcation (Fig. 1). The plasmid was transformed into E. coli BL21 (DE3)
competent cells and grown on an LB plate that contained 30 μg/ml of
kanamycin. Proteinwas puriﬁed intoDPC and LMPGmicelles as previous-
ly described [22].
2.3. Backbone assignment
All spectra were acquired at 313 K on a Bruker Avance II 600 MHz
spectrometer equipped with a triple-resonance cryoprobe. Spectrawere processed with Topspin 2.1 (Bruker) and NMRPipe [29] and visu-
alizedwithNMRView [30] or Sparky. A sample that contained 0.5mMof
13C/15N-labeled NS4B1–125, 20 mMNa-phosphate, pH 6.5, 1% LMPG and
10%D2Owas used for data collection. The backbone 1HN, 1Hα, 15N, 13Cα
and 13C′ resonances were assigned using two dimensional (2D) and
three dimensional (3D) experiments including 1H-15N-HSQC, 3D-
HNCO, HNCACB, CBCA(CO)NH and HNCA [31]. Side-chain 1H and 13C
resonances were assigned using 3D-HNCACB, HBHA(CO)HN and
[1H-15N]-HSQC-NOESY (mixing time = 120 ms) experiments. Protein
secondary structure was analyzed using TALOS+ [32]. The spectra
were processed with NMRPipe [29] and analyzed using NRMView
[30], Sparky (http://www.cgl.ucsf.edu/home/sparky/), and CARA
(http://www.mol.biol.ethz.ch/groups/wuthrich_group).
2.4. Protein relaxation analysis
The 15N longitudinal T1, and transverse T2 relaxation rates [33] were
measured at 313 K using a 15N-labeled sample. For T1 measurements,
the spectra with relaxation delays of 50, 100, 300, 500, 800, 1000,
1400, 1800, 2500 and 3000 ms were recorded. For T2 measurements,
the data were acquired with delays of 16.9, 34, 51, 68, 85, 102, 119,
and 136 ms. 1H-15N-heteronuclear NOE (hetNOE) experiments were
obtained using two datasets thatwere collectedwith andwithout initial
proton saturation for a period of 3 s.
2.5. Circular dichroism (CD) analysis
The CD experimentwas performed on a Chirascan™ circular dichro-
ism spectrometer as previously described [34]. Puriﬁed NS4B1–125 was
diluted to a concentration of 25 μM in a buffer containing 20 mM sodi-
um phosphate at a pH of 6.5, 0.5% DPC or 0.1% LMPG. Protein sample
was placed in a quartz cuvette with 1-mm path length. The reference
spectrum was recorded using a buffer containing no protein sample.
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pitch and a 1-nm bandwidth.
2.6. Paramagnetic relaxation enhancement (PRE) and hydrogen-deuterium
(H-D) exchange experiments
A PRE experiment was performed by stepwise addition of a para-
magnetic substance to a 15N labeled NS4B1–125. Gadolinium solution
was freshly prepared and mixed with EDTA with a molar ratio of 1:3.
Protein was ﬁrst prepared in detergent micelles as aforementioned.
The 1H-15N-HSQC spectra of protein in the absence and presence of gad-
oliniumwere recorded and processed. If a residue is exposed to the sol-
vent, line broadening of the signal in the spectrumwill be observed. For
the H-D exchange experiment, puriﬁed protein was frozen in liquid ni-
trogen. The sample was then lyophilized at a low temperature and low
pressure. D2O (99.9%) was then added to the lyophilized sample and
1H-15N-HSQC spectrumwas acquired. The spectrumwas also compared
with the one derived from the sample before lyophilization to make
sure that there is no change during the frozen and lyophilization steps.
3. Results
3.1. Puriﬁcation of NS4B1–125
Using a biochemical approach,Miller et al. proposed amembrane to-
pology of DENV NS4B protein (Fig. 1A) [15]. The ﬁrst two predicted
transmembrane domains (pTMD) are located in the ER lumen, followed
by three real transmembrane domains (TMD). The aimof this study is to
deﬁne the secondary structure of the N-terminal portion of the DENV
NS4B using NMR spectroscopy. We initially attempted to express the
ﬁrst 101 amino acids of NS4B protein, but the solubility of this construct
was low (Fig. S1) and it could only be puriﬁed in the presence of deter-
gent (Fig. S1). As NS4B is a membrane protein, its N-terminal region is
close to or embedded in the cell membrane. Studying the structure of
this region in cell membrane or a membrane-mimicking system such
as detergent micelles will simulate its structure under the physiological
conditions [35]. We then made another construct NS4B1–125 containing
residues 1–125 of NS4B followed by seven non-viral residues
(EHHHHHH) at the C-terminus to facilitate protein puriﬁcation
(Fig. 1B). NS4B1–125 includes the N-terminal region located in the ER
lumen and the ﬁrst TMD (Fig. 1B). We did not include residues 126–
129 in the protein construct based on two observations. First, sequence
analysis and TM prediction using web servers HMMTOP (http://www.
enzim.hu/hmmtop/) (Fig. 1B) and TMHMM (http://www.cbs.dtu.dk/
services/TMHMM-2.0/) (Fig. 1C) suggested that residues 126 to 129
(QAKA; strikeout in Fig. 1B) are not buried in the membrane. Second,Fig. 2. 1H-15N-HSQC spectra of NS4B1–125 in DPC (5%) and LMPG (1%) micelles. All the experim
spectrum in LMPG micelles.a previous study showed that the ﬁrst 125 amino acids of DENV NS4B
are functionally sufﬁcient for inhibition of alpha/beta interferon signal-
ing [36]. NS4B1–125 can be expressed and puriﬁed from E. coli and
reconstituted into detergent micelles (Fig. S2).
3.2. Detergent screening for NS4B1–125
Detergent micelles are used as a membrane-mimetic to study struc-
ture and function of membrane proteins in vitro. We found four deter-
gents (SDS, DPC, CHAPS, and LMPG) that could be used for NS4B1–125
puriﬁcation. As SDS is a harsh detergent that can denature proteins,
we chose to collect 1H-15N-HSQC spectra for NS4B1–125 in DPC, CHAPS,
and LMPG. High-quality NMR spectra were obtained when NS4B1–125
was prepared in both DPC and LMPG micelles (Fig. 2). The narrow dis-
persion of cross peaks over proton chemical shift range from 7.4 ppm
to 9.0 ppm is typical for a folded helical protein (Fig. 2). Far-UV CD spec-
tra indicated the presence of helical structures of NS4B1–125 in both de-
tergents (Fig. S3). The spectral quality of NS4B1–125 in CHAPS was low
(data not shown). There are two Trp residues (W38 and W82) present
in NS4B1–125 sequence; however, three Trp indole peaks were observed
under both DPC and LMPG conditions, suggesting that one of the resi-
dues may have different conformations (Fig. 2). As the 1H-15N-HSQC
spectrum of NS4B1–125 puriﬁed into LMPG micelles exhibited expected
cross peaks, including all the expected Gly and Trp indole side chain
peaks, further NMR study was carried out in LMPG micelles.
3.3. Secondary structure analysis for NS4B1–125
Backbone resonance assignment for NS4B1–125 was obtained using
conventional 3D experiments. Nearly complete backbone amide and
amide protonswere assigned (Fig. 3A). The assignment has been depos-
ited into the BiomagResBank with accession number 26637. The sec-
ondary structure was ﬁrst deﬁned based on backbone resonance
chemical shifts using TALOS+ [32]. There are ﬁve helices present in
NS4B1–125, namely α1 formed by residues 5 to 12, α2 formed by resi-
dues 35 to 57, α3 formed by residues 65 to 77, α4 formed by residues
92 to 96 and α5 formed by residues 104–124 (Fig. 3B). The helix α2
contains a break due to the presence of a proline residue at position
50. We also collected 3D NOESY experiments to conﬁrm the secondary
structures. For α2 and α5, NOE connectivities are consistent with
TALOS+ prediction (Fig. 3C). Different results were observed for α1,
α3 andα4. NOE analysis suggested that these three helices were longer
than the ones predicted from TALOS+, which may arise from the dy-
namic nature of these helices (Fig. 3C). The secondary structures of
NS4B1–125 were then deﬁned based on the NOE connectivities and dy-
namic results (Fig. 3C, D, E, and Fig. 4). Dynamic analysis of NS4B1–125ents were conducted at 313 K. Left panel is the spectrum in DPC and the right panel of the
Fig. 3. Secondary structural analysis of NS4B1–125. A. Assignment of the 1H-15N-HSQC spectrum of NS4B1–125 in LMPG micelles. The cross peaks in the spectrum are labeled with residue
name and sequence number. B. TALOS+ analysis of NS4B1–125. The probability (0–1) to be a helix or not is plotted against residue number. C. Dynamic analysis of NS4B1–125. The RCI-S2
values derived from TALOSN are plotted based on the backbone resonance chemical shifts. A value more than 0.85 (dashed line) suggests that a residue is rigid. D. NOE connectivity of
NS4B1–125. The secondary structure was deﬁned based on NOE connectivities. E. Helix wheel presentation of the helices identiﬁed in this study.
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loop betweenα2 and α3 are ﬂexible (Fig. 3C). The α1 and α4 were not
as rigid as the other helices (Fig. 3C). Residues from E2 to G16 form α1.
Although residues fromS17 to T20 have a tendency to be helical as NOEs
of Hαi to HNi + 3 were observed, their high T2 values in solution sug-
gested that theymay not form a stable helix (Fig. 4). Helix wheel repre-
sentation for the identiﬁed helices except for the short helixα4 (Fig. 3D)
wasmade to identify possible amphipathic helices. Theα2 contains sev-
eral hydrophilic residues and no hydrophilic patch was identiﬁed, sug-
gesting that it can be a TM region. The α3 behaves like an
amphipathic helix containing a larger hydrophilic surface and smaller
hydrophilic surface formed by residues N62, T66, A69, N70, T73, and
K80. The transmembrane helix α5 is mainly hydrophobic with no hy-
drophilic patch identiﬁed (Fig. 3D).
3.4. Dynamic analysis of NS4B1–125 in LMPG micelles
The backbone dynamics of NS4B1–125 in LMPG micelles was studied
by themeasurement of 15N longitudinal T1 and transverse T2 relaxation
rates and steady-state heteronuclear NOE (hetNOE) values. These dy-
namic parameters are very useful to probe motions of a protein on the
picoseconds to nanosecond time scales. The results are summarized in
Fig. 4. As predicted by TALOSN using backbone resonance chemical
shift, three helices including α2, α3, and α5, are stable in solution. Theﬁrst 30 amino acids exhibited low T1 values. Interestingly, residues
from α1 (2–16) exhibited low T2 values and residues from 16 to 25 ex-
hibited the highest T2 values, indicating that the C-terminus of α1 is
ﬂexible or undergoing exchanges. This result may also explain different
secondary structure obtained fromNOE analysis and TALOS+. Residues
79–104 (including α4) showed lower T1 values than those of α2, α3,
andα5 and their low T2 values suggested that they are still stable in so-
lution (Fig. 4). It has been noted the hetNOE result demonstrated that
the hetNOE values of most residues are below 0.8, suggesting that
they are not forming rigid structures in solution. Interestingly, three he-
lices (α2,α3, andα5) exhibited similar dynamic parameters and exhib-
ited hetNOE values more than 0.6, suggesting that these helices are
stable in solution and α2 and α3 might be interacting or buried in the
micelles while α5 is a transmembrane domain.
3.5. PRE experiment
To further explore possible residues that are exposed to the solvent,
we carried out a PRE experiment using a water accessible probe-
gadolinium. 1H-15N-HSQC of NS4B1–125 in the absence and presence of
gadoliniumwas recorded andprocessed (Fig. 5A). If a residue is exposed
to the solvent, line broadening will be observed. On the other hand, the
signal will not be affected when a residue is buried in the micelles or
protected from solvent exposure [38,39]. The PRE experiment
Fig. 4. Relaxation analysis of NTD of NS4B1–125 in LMPG micelles. T1, T2 and hetNOE values are plotted as a function of residue number, respectively.
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ﬁrst helix α1, are exposed to the solvent except for several residues
that may be interacting with micelles (Fig. 5C). The residues from heli-
ces,α2A, N-terminal part ofα2B,α3, andα4 showed no obvious chang-
es in the peak intensities, suggesting that they may be buried in the
micelles. Interestingly, part of the linker region betweenα3 andα4 con-
taining residue 79 to 87 was also buried in the micelles (Fig. 5). The C-
terminus of the transmembrane helix-α is solvent-exposed (Fig. 5C).
This result suggested that the construct used in this study contains
three possible transmembrane regions: α2, α3, and α5 (Fig. 5). The re-
gion including α4 localizing between α3 and α5 is also solvent
protected, suggesting that this region may interact with the cell mem-
brane. H-D exchange experiment showed that some residues from
these ﬁve helices were protected from exchanges (Fig. 5). However,
fewer residues in α1, α2, α3, and α4 were projected than those from
the transmembrane helix-α5, suggesting that they may not be as stable
as α5 in solution (Fig. 5). A possible membrane topology of NS4B was
proposed based on the structural and PRE analysis (Fig. 5D).3.6. Effect of V63I mutation on the structure of NS4B1–125
Apotent inhibitor targetingNS4B of DENV2 and 3was reported [21].
The residue at position 63 (V63) was shown to be important for the in-
hibitor binding to NS4B1–125. Mutation V63Iweakened compound bind-
ing to NS4B protein in a gel ﬁltration-based assay [21]. To understand
the importance of V63 in NS4B, we compared the 1H-15N-HSQC spectra
of wild type and V63I mutant of NS4B1–125 (Fig. 6). Overall, both wild
type and V63Imutation of NS4B1–125 exhibited similar spectra, suggest-
ing that mutation did not cause signiﬁcant secondary structural chang-
es. However, residues such as L65, A67, and I68 exhibited chemical shift
perturbation upon V63I mutation; this result is not surprising because
these residues are close to V63. Interestingly, some residues in α5
TMD such as A109, H117, I120, I121, and G122 exhibited chemical
shift changes aswell, suggesting that residueV63 or I63may have amo-
lecular interaction with aforementioned residues in the α5 TMD under
certain conditions. V63I mutation might affect its interaction between
V63 and α5 TMD, leading to decreased compound binding to NS4B
protein.4. Discussion
Using solution NMR spectroscopy, NS4B1–125 was demonstrated to
contain ﬁve helices in LMPG micelles. A previous study showed that
the N-terminal region of NS4B contains two helices: helix 1 formed by
residues 32 to 56 and helix 2 formed by residues 60 to 83 [15]. Although
the overall membrane topology of NS4B is known, studies using differ-
ent approaches are needed to deﬁne the details of NS4B structure on the
ER membrane. Three transmembrane segments were identiﬁed using
the computer-based models [15]. A recent study using a peptide library
from NS4B of DENV-2 identiﬁed nine hydrophobic zones in the protein
sequence. Five zones are predicted to be potential transmembrane seg-
ments [26]. In this study, we found that the prediction of NS4B topology
and structure using differentweb servers also produced different results
(Fig. 1). We also found that TALOS+ prediction and NOE connectivity
analysis result in different secondary structural prediction for several
helices (Fig. 3). We ﬁnally deﬁned the secondary structures based on
NOE connectivity (Fig. 3). This may be due to the content of hydrophilic
residues present in the transmembrane regions or the dynamic nature
of this region (Fig. 5). A similar result was also observed for amembrane
protein of DENV-NS2B [28].
NMR spectroscopy has been shown to be an important tool to study
membrane protein structure, dynamic andmembrane topology in vitro.
We showed that there is a helix formed by residues 2–16 (α1) present
at the N-terminus of NS4B1–125,which was not predicted in previous
studies (Fig. 1, 3) [40]. The α2 identiﬁed in the current study is similar
to the helix 1 that was predicted in the previous study (compare
Fig. 1A with Fig. 3B) [40]. The identiﬁed α3 (61–82) was similar to the
helix 2 (60–83) that was predicted in the previous study [15]. We also
identiﬁed another short helix (α4) containing residues 92 to 96. The
reason that these two additional helices (α1 and α4) were not identi-
ﬁed in the previous studymight due to their dynamic nature andmem-
brane environment such as micelles may favor the formation of helical
structures (Fig. 4). Based on relaxation data, the ﬁrst helix is ﬂexible,
which might be important for maturation of NS4B because there is a
host protease cleavage site between 2 K peptide and NS4B. The ﬂexible
regionmight be easily recognized by the host protease. There is one Pro
residue present in the helix α2, which produced a kink structure. This
kinked helix may have more ﬂexibility to interact with other proteins
Fig. 5. PRE analysis of NS4B1–125. A. 1H-15N-HSQC of NS4B1–125 in the absence and presence (2 mM) of gadolinium. The 1H-15N-HSQC spectra of NS4B1–125 in the absence and presence of
gadoliniumwere collected and processed. B. 1H-15N-HSQC of NS4B1–125 in D2O. The spectrum was recorded 10 min after adding D2O. Cross-peaks are labeled with residue name and se-
quence number. C. The relative peak intensities in the absence (I0) and presence (Ip) of 2mMgadoliniumwere plotted. D. One possiblemembrane topology of NS4B1–125. The residues that
are protected from H-D exchange are highlighted in red. The identiﬁed helices are highlighted with boxes. The line at the C-terminus indicates the EHHHHHH residues.
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helix α4 was identiﬁed. PRE experiment demonstrated that this helix
was not exposed to the solvent (Fig. 5). It is interesting that there is a
Pro residue (P104) at the beginning of the transmembrane helix α5.
This Pro residue is important for NS4B function because P104Lmutation
was shown to abolish its interaction with NS3 [10]. Another study
showed that P104L mutation could cause resistance to an NS4B inhibi-
tor derived from a high-throughput screening [23]. Mutation of P104
might favor forming a longer helix formed byα4 andα5,whichmay af-
fect NS4B's structure and function. Our relaxation results also suggested
thatα2,α3 andα5 have similarmotions under micelle conditions, sug-
gesting that α2 and α3 may behave like α5-a transmembrane domain.
Helix wheel presentation showed that the α3 is an amphipathic helix
containing a smaller hydrophilic interface (Fig. 3). For the α2 and α3,
further PRE experiment conﬁrmed that these two helices are protected
from solvent exposure, suggesting that theymay be transmembrane re-
gions. The four helices (α2, α3, α4, and α5) identiﬁed in this study
might interact or buried in themembrane based on our PRE anddynam-
ic studies (Fig. 5). It has been noted that our dynamic study also showed
that this construct did not form a very rigid structure in solution and H-
D exchange experiment revealed that only few residues in the heliceswere protected from exchanges (Fig. 5). All these results imply that
the helices may undergo conformational under certain conditions like
NS4A, which also explains why different studies showed different
NS4B membrane topologies [26,40]. A study on the N-terminal region
of NS4A reveals that it is sensitive to membrane curvature [27]. Never-
theless, our current study provided for the ﬁrst time the evidence of
the secondary structures of the N-terminal region of NS4B.
Membrane proteins of DENV play important roles in viral replica-
tion. Studies have shown that NS4B may be responsible for the mem-
brane rearrangement and formation of the replication complex during
viral replication process [15]. Full-length NS4B was shownto form di-
mers and the loop region between TMD1 and TMD2 is important for
protein dimerization. Compared with NS4B of HCV—a member of Flavi-
virus family, the sequence homology of these two proteins is low and
dengue NS4B does not contain the basic leucine zipper motif that is im-
portant for HCV NS4B dimerization [24,25] (Fig. S4). The NS4B1–125
constructe used in this study exists mainly in a monomeric form be-
cause high quality NMR spectra were obtained for NS4B1–125 without
using TROSY-based pulse programs and a high concentration ofmicelles
was present in the sample. Further membrane and protein interaction
studies will provide more information to understand NS4B function.
Fig. 6.Effect ofmutation at position 63onNS4B1–125 structure. TheV63Imutationwasmade using site-directedmutagenesis. Proteinwas expressed andpuriﬁedusing the samemethod as
that of the wild type. 1H-15N-HSQC spectra of NS4B1–125 wild type and V63I mutation were collected and shown. Residues showed chemical shift changes are labeled with residue name
and residue number.
3156 Y. Li et al. / Biochimica et Biophysica Acta 1848 (2015) 3150–3157The N-terminal 125 residues of NS4B can block the IFN-α/β-induced
signal transduction cascade through interferingwith transducer and ac-
tivator of transcription (STAT1) phosphorylation [36]. Interestingly, the
N-terminal region preceding the ﬁrst transmembrane domain
contained the drug binding site. Further structural characterization on
this construct is on ongoing. Based on a previous study, the V63 was
shown to be one of the critical residues for the molecular interaction
with a potent spiropyrazolopyridone inhibitor [22]. This inhibitor is ac-
tive against DENV-2 and -3, but not -1 and -4. Sequence alignment re-
vealed that NS4B from DENV1 or 4 contains Ile residue at position 63
[22]. The V63I mutation in both full length NS4B and NS4B1–125 reduced
compound binding [22]. Superimposed 1H-15N-HSQC spectra of wild
type NS4B1–125 and the V63Imutant showed that the chemical environ-
ment of residues in the α5 TMD such as H117 and I121 was affected by
the point mutation, suggesting that V63 or I63 might have interactions
with the α5 TMD. NS4B also interacts with other DENV proteins such
as NS3 and NS4A [12,14]. Further structural study on NS4B1–125 and its
intact form will provide more information to understand its function,
which will aid in drug discovery targeting DENV.
In conclusion, our results show that there are ﬁve helices present in
NS4B1–125. The ﬁrst helix α1 is ﬂexible and there are two possible
transmembrane helices (α2 and α3) present preceding the ﬁrst
transmembrane domain (α5). V63 might have close contacts with the
TMD formed by residues 104 to 124. The current study provides de-
tailed secondary structural information for the N-terminal region of
NS4B. However, it should be noted that the current structural informa-
tion of NS4B1–125 was analyzed in the absence of C-terminal half of the
complete NS4B protein. Experiments are ongoing to solve the structure
of complete NS4B protein.Conﬂict of interest
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